Maria J Worsham1, George Divine, Rick A Kittles. 1. Department of Otolaryngology/Head and Neck Surgery, Henry Ford Health System, Detroit, MI 48202, USA. mworsha1@hfhs.org
Abstract
OBJECTIVE: The authors examined ancestry informative markers (AIMs) to estimate the amount of population admixture and control for this heterogeneity for stage and survival in a primary head and neck squamous cell carcinoma (HNSCC) cohort. STUDY DESIGN: Historical cohort study. SETTING: Integrated health care system. SUBJECTS: The cohort comprised 358 patients with HNSCC who self-reported race as Caucasian American (CA), African American (AA), or other. METHODS: DNA was interrogated for West African (WA) and European genetic background by genotyping AIMs. Associations of race (self-report or WA ancestry) with stage and survival were analyzed using logistic regression and Cox regression modeling. A subgroup analysis for diagnosis (late vs early stage) and survival (time to death) and WA ancestry was performed for self-reported AAs. RESULTS: There were significant associations between stage and self-reported race (P = .04 [univariate]) and with cancer site (oropharynx: P = .014; hypopharynx: P = .026 [multivariate]). For prognosis, there were significant multivariate associations between stage (P = .002), age (>65 years, P < .001), and cancer site (hypopharynx: P < .001; oral cavity: P = .049), but self-reported race was not associated with overall survival. Interestingly, there was no association with degree of WA ancestry and stage or survival. In the subgroup analysis of genetic ancestry among self-reported AAs, cancer site remained an independent risk factor for stage (other site: P = .026) and survival (oropharynx: P = .036). Late stage persisted as an independent variable for poor survival (P = .032). CONCLUSIONS: Stratification within AAs by WA ancestry revealed no correlation with stage or survival, suggesting that HNSCC outcomes with race may be owing to social/behavior factors rather than biological differences.
OBJECTIVE: The authors examined ancestry informative markers (AIMs) to estimate the amount of population admixture and control for this heterogeneity for stage and survival in a primary head and neck squamous cell carcinoma (HNSCC) cohort. STUDY DESIGN: Historical cohort study. SETTING: Integrated health care system. SUBJECTS: The cohort comprised 358 patients with HNSCC who self-reported race as Caucasian American (CA), African American (AA), or other. METHODS: DNA was interrogated for West African (WA) and European genetic background by genotyping AIMs. Associations of race (self-report or WA ancestry) with stage and survival were analyzed using logistic regression and Cox regression modeling. A subgroup analysis for diagnosis (late vs early stage) and survival (time to death) and WA ancestry was performed for self-reported AAs. RESULTS: There were significant associations between stage and self-reported race (P = .04 [univariate]) and with cancer site (oropharynx: P = .014; hypopharynx: P = .026 [multivariate]). For prognosis, there were significant multivariate associations between stage (P = .002), age (>65 years, P < .001), and cancer site (hypopharynx: P < .001; oral cavity: P = .049), but self-reported race was not associated with overall survival. Interestingly, there was no association with degree of WA ancestry and stage or survival. In the subgroup analysis of genetic ancestry among self-reported AAs, cancer site remained an independent risk factor for stage (other site: P = .026) and survival (oropharynx: P = .036). Late stage persisted as an independent variable for poor survival (P = .032). CONCLUSIONS: Stratification within AAs by WA ancestry revealed no correlation with stage or survival, suggesting that HNSCC outcomes with race may be owing to social/behavior factors rather than biological differences.
Authors: Heather E Collins-Schramm; Carolyn M Phillips; Darwin J Operario; Jane S Lee; James L Weber; Robert L Hanson; William C Knowler; Richard Cooper; Hongzhe Li; Michael F Seldin Journal: Am J Hum Genet Date: 2002-02-11 Impact factor: 11.025
Authors: K Kian Ang; Jonathan Harris; Richard Wheeler; Randal Weber; David I Rosenthal; Phuc Felix Nguyen-Tân; William H Westra; Christine H Chung; Richard C Jordan; Charles Lu; Harold Kim; Rita Axelrod; C Craig Silverman; Kevin P Redmond; Maura L Gillison Journal: N Engl J Med Date: 2010-06-07 Impact factor: 91.245
Authors: Heather E Collins-Schramm; Bill Chima; Darwin J Operario; Lindsey A Criswell; Michael F Seldin Journal: Hum Genet Date: 2003-06-03 Impact factor: 4.132
Authors: M L Gillison; W M Koch; R B Capone; M Spafford; W H Westra; L Wu; M L Zahurak; R W Daniel; M Viglione; D E Symer; K V Shah; D Sidransky Journal: J Natl Cancer Inst Date: 2000-05-03 Impact factor: 13.506
Authors: Sonia S Kupfer; Jeffrey R Anderson; Stanley Hooker; Andrew Skol; Rick A Kittles; Temitope O Keku; Robert S Sandler; Nathan A Ellis Journal: Gastroenterology Date: 2010-07-24 Impact factor: 22.682
Authors: Atsushi Terunuma; Nagireddy Putluri; Prachi Mishra; Ewy A Mathé; Tiffany H Dorsey; Ming Yi; Tiffany A Wallace; Haleem J Issaq; Ming Zhou; J Keith Killian; Holly S Stevenson; Edward D Karoly; King Chan; Susmita Samanta; DaRue Prieto; Tiffany Y T Hsu; Sarah J Kurley; Vasanta Putluri; Rajni Sonavane; Daniel C Edelman; Jacob Wulff; Adrienne M Starks; Yinmeng Yang; Rick A Kittles; Harry G Yfantis; Dong H Lee; Olga B Ioffe; Rachel Schiff; Robert M Stephens; Paul S Meltzer; Timothy D Veenstra; Thomas F Westbrook; Arun Sreekumar; Stefan Ambs Journal: J Clin Invest Date: 2013-12-09 Impact factor: 19.456